Who owns the REVERAGEN BIOPHARMA trademark?

The REVERAGEN BIOPHARMA trademark is owned by ReveraGen Biopharma, Inc..

What class is the REVERAGEN BIOPHARMA trademark registered in?

The REVERAGEN BIOPHARMA trademark is registered in Class 042 (Scientific, technology & SaaS services).

What is the serial number for REVERAGEN BIOPHARMA?

The USPTO serial number for REVERAGEN BIOPHARMA is 86386224.

What is the registration number for REVERAGEN BIOPHARMA?

REVERAGEN BIOPHARMA is registered under USPTO registration number 4742704.

Sealvo

Home Search: REVERAGEN BIOPHARMAREVERAGEN BIOPHARMA #86386224

Back

Updated Oct 12, 2026·34 searches this week

View on USPTO TSDR Find similar marks

REV

USPTO Trademark Record

REGISTERED

REVERAGEN BIOPHARMA

SN 86386224·Reg 4742704·Filed Sep 05, 2014

Owner ReveraGen Biopharma, Inc.

Scientific and technological services and research and design relating thereto; industrial analysis, industrial research and industrial design services; quality control and authentication services; design and development of computer hardware and software.

REVERAGEN BIOPHARMA (Serial No. 86386224), Registration No. 4742704, is a registered US trademark filed on Sep 05, 2014 by ReveraGen Biopharma, Inc.. This trademark covers Class 042 (Scientific, technology & SaaS services).

Section 8/9 declaration window: May 28, 2035

Mark Intelligence

REVERAGEN BIOPHARMA (Reg. #4742704) is a registered US trademark that has been protecting its owner, ReveraGen Biopharma, Inc., since 2014. The mark covers Class 042 (Scientific, technology & SaaS services). Goods and services include Scientific and technological services and research and design relating thereto; industrial analysis, industrial research.... The mark faced 1 opposition proceeding during prosecution.

FILED

Sep 05, 2014

SERIAL

86386224

REG#

4742704

REGISTERED

May 26, 2015

Filing Information

StatusREGISTERED

Filing DateSep 05, 2014

Serial Number86386224

Registration No.4742704

Registration DateMay 26, 2015

Status DateJul 31, 2025

Published for OppositionMar 10, 2015

Filing Basis & Declarations

Filed as Use ApplicationUse Application CurrentlySection 8 AcceptedSection 15 Acknowledged

Full Goods & Services

CLASSES

OFFICE

USPTO

COUNTRY

Class 042Scientific, technology & SaaS services

US codes: 100, 101

First use anywhere: Mar 15, 2011

First use in commerce: Jan 13, 2014

This description is as filed with the USPTO and defines the scope of trademark protection.

Run a conflict check

Search by serial number, mark name, or logo. See conflicting marks ranked by risk with clear explanations of what contributed.

Run conflict check

Status History

31 events

CASE ASSIGNED TO POST REGISTRATION PARALEGAL

Jul 31, 2025

CASE ASSIGNED TO POST REGISTRATION PARALEGAL

REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED

Jul 31, 2025

REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED

REGISTERED AND RENEWED (FIRST RENEWAL - 10 YRS)

Jul 31, 2025

REGISTERED AND RENEWED (FIRST RENEWAL - 10 YRS)

NOTICE OF ACCEPTANCE OF SEC. 8 & 9 - E-MAILED

Jul 31, 2025

NOTICE OF ACCEPTANCE OF SEC. 8 & 9 - E-MAILED

TEAS SECTION 8 & 9 RECEIVED

Mar 11, 2025

TEAS SECTION 8 & 9 RECEIVED

COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED

May 26, 2024

COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED

CASE ASSIGNED TO POST REGISTRATION PARALEGAL

Aug 09, 2021

CASE ASSIGNED TO POST REGISTRATION PARALEGAL

REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.

Aug 09, 2021

REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.

NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED

Aug 09, 2021

NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED

TEAS SECTION 8 & 15 RECEIVED

Apr 09, 2021

TEAS SECTION 8 & 15 RECEIVED

COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED

May 26, 2020

COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED

TEAS CHANGE OF CORRESPONDENCE RECEIVED

Apr 08, 2019

TEAS CHANGE OF CORRESPONDENCE RECEIVED

Oct 11, 2016

TEAS CHANGE OF CORRESPONDENCE RECEIVED

REGISTERED-PRINCIPAL REGISTER

May 26, 2015

REGISTERED-PRINCIPAL REGISTER

PUBLISHED FOR OPPOSITION

Mar 10, 2015

PUBLISHED FOR OPPOSITION

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

Mar 10, 2015

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED

Feb 18, 2015

NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED

ASSIGNED TO LIE

Feb 03, 2015

ASSIGNED TO LIE

LAW OFFICE PUBLICATION REVIEW COMPLETED

Feb 03, 2015

LAW OFFICE PUBLICATION REVIEW COMPLETED

APPROVED FOR PUB - PRINCIPAL REGISTER

Jan 14, 2015

APPROVED FOR PUB - PRINCIPAL REGISTER

TEAS RESPONSE TO OFFICE ACTION RECEIVED

Jan 06, 2015

TEAS RESPONSE TO OFFICE ACTION RECEIVED

CORRESPONDENCE RECEIVED IN LAW OFFICE

Jan 06, 2015

CORRESPONDENCE RECEIVED IN LAW OFFICE

TEAS/EMAIL CORRESPONDENCE ENTERED

Jan 06, 2015

TEAS/EMAIL CORRESPONDENCE ENTERED

ASSIGNED TO EXAMINER

Dec 17, 2014

ASSIGNED TO EXAMINER

APPROVED FOR PUB - PRINCIPAL REGISTER

Dec 17, 2014

APPROVED FOR PUB - PRINCIPAL REGISTER

PREVIOUS ALLOWANCE COUNT WITHDRAWN

Dec 17, 2014

PREVIOUS ALLOWANCE COUNT WITHDRAWN

NON-FINAL ACTION WRITTEN

Dec 17, 2014

NON-FINAL ACTION WRITTEN

NON-FINAL ACTION E-MAILED

Dec 17, 2014

NON-FINAL ACTION E-MAILED

NOTIFICATION OF NON-FINAL ACTION E-MAILED

Dec 17, 2014

NOTIFICATION OF NON-FINAL ACTION E-MAILED

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

Sep 16, 2014

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

NEW APPLICATION ENTERED

Sep 09, 2014

NEW APPLICATION ENTERED

Other Marks by ReveraGen Biopharma, Inc.

Additional USPTO filings from the same owner.

REV

REVERAGEN

86386229

ReveraGen Biopharma, Inc.

REGISTERED

REV

REVERA GEN

85466781

Reveragen Biopharma, Inc

ABANDONED

REV

REVERAGEN

85466817

Reveragen BioPharma, Inc

ABANDONED

Other Marks in Class 042 — Scientific, technology & SaaS services

Recently filed and registered marks in the same international class.

REV

REVERAGEN

86386229

ReveraGen Biopharma, Inc.

REGISTERED

HAN

HANSA BIOPHARMA

99652411

HANSA BIOPHARMA AB

REGISTERED

THE

THERAVANCE BIOPHARMA

79260681

Theravance Biopharma Ireland Limited

REGISTERED

HAN

HANSA BIOPHARMA

88196717

HANSA BIOPHARMA AB

REGISTERED

Other Marks by Tim Burgdorf

Additional USPTO filings handled by the same attorney of record.

ASS

ASSERTIO SPECIALTY PHARMACEUTICALS

99084137

REGISTERED

REN

RENEWAL WATCH

99537185

REGISTERED

DOC

DOCUMENT SHIELD

99537172

REGISTERED

GOV

GOV+

99557445

REGISTERED

REVERAGEN BIOPHARMA

Run a conflict check

Other Marks by ReveraGen Biopharma, Inc.

Other Marks in Class 042 — Scientific, technology & SaaS services

Other Marks by Tim Burgdorf

Get pre-filing clearance

Search 14M+ trademarks

Resources

Company